Estrella Historical Balance Sheet
| ESLA Stock | 0.99 0.02 2.00% |
Trend analysis of Estrella Immunopharma balance sheet accounts such as Total Stockholder Equity of 3.2 M or Accounts Payable of 0.0 provides information on Estrella Immunopharma's total assets, liabilities, and equity, which is the actual value of Estrella Immunopharma to its prevalent stockholders. By breaking down trends over time using Estrella Immunopharma balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Estrella Immunopharma latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Estrella Immunopharma is a good buy for the upcoming year.
Estrella |
About Estrella Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Estrella Immunopharma at a specified time, usually calculated after every quarter, six months, or one year. Estrella Immunopharma Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Estrella Immunopharma and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Estrella currently owns. An asset can also be divided into two categories, current and non-current.
Estrella Immunopharma Balance Sheet Chart
Add Fundamental
Accounts Payable
An accounting item on the balance sheet that represents Estrella Immunopharma obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Estrella Immunopharma are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Most accounts from Estrella Immunopharma's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Estrella Immunopharma current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Estrella Immunopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Estrella Stock refer to our How to Trade Estrella Stock guide.At present, Estrella Immunopharma's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Invested Capital is expected to grow to about 5.2 M, whereas Total Current Liabilities is forecasted to decline to about 154.5 K.
| 2022 | 2024 | 2025 (projected) | Other Stockholder Equity | 19.3M | 27.3M | 15.8M | Other Current Assets | 11.6K | 10.5K | 9.9K |
Estrella Immunopharma balance sheet Correlations
Click cells to compare fundamentals
Estrella Immunopharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Estrella Immunopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Estrella Stock refer to our How to Trade Estrella Stock guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Estrella Immunopharma. If investors know Estrella will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Estrella Immunopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Estrella Immunopharma is measured differently than its book value, which is the value of Estrella that is recorded on the company's balance sheet. Investors also form their own opinion of Estrella Immunopharma's value that differs from its market value or its book value, called intrinsic value, which is Estrella Immunopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Estrella Immunopharma's market value can be influenced by many factors that don't directly affect Estrella Immunopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Estrella Immunopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Estrella Immunopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Estrella Immunopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.